Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Chappell

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|March 5, 1994
Sequential use of opioid antagonists and agonists in Tourette's syndromeP B Chappell
JAMA|June 10, 1992
Final exit and the risk of suicideP B Chappell, R A King, M Enson
Neurologic Clinics|May 1, 1997
Future therapies of Tourette syndromeP B Chappell, L D Scahill, J F Leckman
Child and Adolescent Psychiatric Clinics of North America|February 16, 2000
Pharmacologic treatment of tic disordersL Scahill, P B Chappell, R A King, et al.
Nucleic Acids Research|August 25, 1990
Polymorphism at the D20S13 (p phi 64) locusP B Chappell, A J Pakstis, C H Carr, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 1, 1994
Clozapine in the treatment of a young adolescent with schizophreniaL K Jacobsen, M C Walker, J E Edwards, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
Patterns of response to acute naloxone infusion in Tourette's syndromeP J van Wattum, P B Chappell, D Zelterman, et al.
Psychiatry Research|June 1, 1993
Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: a pilot studyP B Chappell, J F Leckman, L D Scahill, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1986
Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stressP B Chappell, M A Smith, C D Kilts, et al.
Advances in Neurology|January 1, 1995
Tourette's syndrome: a multigenerational, neuropsychiatric disorderP J Lombroso, L D Scahill, P B Chappell, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|March 5, 1994
Sequential use of opioid antagonists and agonists in Tourette's syndromeP B Chappell
JAMA|June 10, 1992
Final exit and the risk of suicideP B Chappell, R A King, M Enson
Neurologic Clinics|May 1, 1997
Future therapies of Tourette syndromeP B Chappell, L D Scahill, J F Leckman
Child and Adolescent Psychiatric Clinics of North America|February 16, 2000
Pharmacologic treatment of tic disordersL Scahill, P B Chappell, R A King, et al.
Nucleic Acids Research|August 25, 1990
Polymorphism at the D20S13 (p phi 64) locusP B Chappell, A J Pakstis, C H Carr, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 1, 1994
Clozapine in the treatment of a young adolescent with schizophreniaL K Jacobsen, M C Walker, J E Edwards, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
Patterns of response to acute naloxone infusion in Tourette's syndromeP J van Wattum, P B Chappell, D Zelterman, et al.
Psychiatry Research|June 1, 1993
Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: a pilot studyP B Chappell, J F Leckman, L D Scahill, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1986
Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stressP B Chappell, M A Smith, C D Kilts, et al.
Advances in Neurology|January 1, 1995
Tourette's syndrome: a multigenerational, neuropsychiatric disorderP J Lombroso, L D Scahill, P B Chappell, et al.
Pageof 3